CHALLENGES WITH DEFINING CLINICAL MEANINGFULNESS IN CNS DISEASES - ACT-AD

4 | ACT-AD LINIAL MEANINGFULNESS IN DRUG DEVELOPMENT FOR EARLY ALZHEIMER’S DISEASE | NOVEMER, 2014 BEYOND EFFICACY IN ISOLATION “Suppose a well-done randomized clinical trial (RCT) reports a statistically significant difference between treatment (T) and control (C) groups, with p=.05, p=.01, even p=10-6.Should these results be ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download